Gene therapy strategies for leukemia

Molecular Medicine Today

Volumn 3, Issue 1, 1997, Pages 39-46

  Braun, S E ^a   Chen, K ^a   Battiwalla, M ^a   Cornetta, K ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; VIRUS VECTOR;

BONE MARROW TRANSPLANTATION; GENE ACTIVATION; GENE MUTATION; GENE TARGETING; GENE THERAPY; HUMAN; LEUKEMIA; RELAPSE; RETROVIRUS; REVIEW; SUICIDE GENE; SURVIVAL;

HERPES; UNIDENTIFIED RETROVIRUS;

EID: 0031408818     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(96)10052-6     Document Type: Review

References (51)

1. Smetsers T. Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173 Leukemia 8 1994 129 140
2. Smetsers T. Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular Bcr-abl protein levels Leukemia 9 1995 118 130
3. Skorski T. Highly efficient elimination of Philadelphia leukemic cells by exposure to bcr/abl antisense oligodeoxynucleotides combined with mafosfamide J. Clin. Invest. 92 1993 194 202
4. Szczylik C. Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides Science 253 1991 562 565
5. Ratajczak M. In vivo treatment of human leukemia in a SCID mouse model with c-myb antisense oligodeoxynucleotides Proc. Natl. Acad. Sci. U. S.A. 80 1992 11823 11827
6. Skorski T. c-RAF-1 serine/threonine kinase is required in BCR/ABL-dependent and normal hematopoiesis Cancer Res. 55 1995 2275 2278
7. Calabretta B. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging Proc. Natl. Acad. Sci. U. S.A. 88 1991 2351 2355
8. Heikkila R. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1 Nature 328 1987 445 449
9. Ratajczak M. Acute-and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligonudeotides Blood 79 1992 1956 1961
10. bcr/abl : implication for RAS-dependent Philadelphia chromosome positive cell growth J. Exp. Med. 179 1994 1855 1865
11. Citro G. Inhibition of leukemia cell proliferation by receptormediated uptake of c-myb antisense oligodeoxynucleotides Proc. Natl. Acad. Sci. U. S. A. 89 1992 7031 7035
12. O'Brien S. Antisense BCR-ABL oligomers cause nonspecific inhibition of chronic myeloid leukemia cell lines Leukemia 8 1994 2156 2162
13. Bayever E. Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trial Antisense Res. Dev. 3 1993 383 390
14. Cornetta K. Safety aspects of gene therapy Br. J. Haematol. 80 1992 421 426
15. Ho P.T. Ishiguro K. Wickstrom E. Sartorelli A.C. Non-sequence-specific inhibition of transferrin receptor expression in HL-60 leukemia cells by phosphorothioate oligodeoxynucleotides Antisense Res. Dev. 1 1991 329 342
16. Kirkland M. BCR-ABL antisense purging in chronic myeloid leukaemia Lancet 342 1993 614
17. Tari A. Tucker S. Deisseroth A. Lopez-Berestein G. Liposomal delivery of methylphosphonate antisense oligonucleotides in chronic myelogenous leukemia Blood 84 1994 601 607
18. Nabel G. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans Proc. Natl. Acad. Sci. U. S. A. 90 1993 11307 11311
19. Haseloff J. Gerlach W. Simple RNA enzymes with new and highly specific endoribonuclease activity Nature 334 1988 585 591
20. Lange W. Cantin E. Finke J. Dolken G. In vitro and in vivo effects of synthetic ribozymes targeted against BCR/ABL mRNA Leukemia 7 1993 1786 1794
21. Wright Z. Ribozyme-mediated cleavage of the bcr/abl transcript expressed in chronic myeloid leukemia Exp. Hematol. 21 1993 1714 1719
22. Snyder D. Ribozyme-mediated inhibition of bcr-abl gene expression in a Philadelphia chromosome-positive cell line Blood 82 1993 600 605
23. Leopold L. Multi-unit ribozyme-mediated cleavage of bcr-abl mRNA in myeloid leukemias Blood 85 1995 2162 2170
24. Lange W Dashalakis M. Finke J. Dolken G. Comparison of different ribozymes for efficient and specific cleavage of BCR/ABL related mRNAs FEBS Lett. 338 1994 175 178
25. Inaba T. DNA-binding specificity and trans -activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein Mol. Cell. Biol. 14 1994 34003 34013
26. Bielinska A. Shivdasani R.A. Zhang L. Nabel G.J. Regulation of gene expression with double-stranded phosphorothioate oligonudeotides Science 250 1990 997 1000
27. Chu B.C.F. Orgel L.E. The stability of different forms of double-stranded decoy DNA in serum and nuclear extracts Nucleic Acids Res. 20 1992 5857 5858
28. Postel E.H. Flint S.J. Kessler D.J. Hogan M.E. Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels Proc. Natl. Acad. Sci. U. S. A. 88 1991 8227 8231
29. bcr-abl expression and inhibit the proliferation of BCR/ABL-containing cell lines Blood 81 1993 502 509
30. + cells Exp. Hematol. 23 1995 906
31. Leemhuis T. Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow Blood 81 1993 801 807
32. Verfaillie C.M. Miller W.J. Boylan K. McGlave P.B. Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression Blood 79 1992 1003 1010
33. − bone marrow progenitors Exp. Hematol. 23 1995 934
34. Cornetta K. A retroviral vector expressing human interferon γ upregulates MHC antigen expression in human breast cancer and leukemia cell lines Cancer Gene Ther. 1 1994 91 98
35. Gansbacher B. Retroviral vector-mediated γ-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity Cancer Res. 50 1990 7820 7825
36. Cornetta K. Retroviral mediated gene transfer in chronic myelogenous leukemia Br. J. Haematol. 87 1994 308 316
37. Tani K. Development of antileukemia immunity using GM-CSF or B7.1 gene-transduced leukemia cells in vivo in mice Blood 86 Suppl. 1 1995 1006a
38. Hirst W. Comparison of B7.1 and interleukin-2 (IL-2) in the rejection of a murine myeloid leukemia Blood 86 Suppl. 1 1995 414a
39. Dranoff G. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity, Proc. Natl. Acad. Sci. U. S. A. 90 1993 3539 3543
40. Horowitz M.M. New IBMTR/ABMTR slides summarize current use and outcome of allogeneic and autologous transplants IBMTR Newsletter 2 1995 1 8
41. Rosenberg S.A. Gene transfer into humans — immunotherapy of patients with advanced melanoma, using tumor infiltrating lymphocytes modified by retroviral gene transduction New Engl. J. Med. 323 1990 570 578
42. Gulati S.C. Romero C.E. Ciavarella D. Is bone marrow purging proving to be of value? Oncology 8 1994 19 24
43. Brenner M.K. Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients Lancet 342 1993 1134 1137
44. Brenner M.K. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation Lancet 341 1993 85 86
45. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow transplant in CML Blood 83 1994 3068 3076
46. Heslop H.E. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes Nat. Med. 2 1996 551 555
47. Tiberghien P. Gancyclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood 84 1994 1333 1341
48. Bonini C. Immunity against the transgene product may limit efficacy of HSV-Tk-transduced donor peripheral blood lymphocytes after allo-BMT Blood 86 Suppl. 1 1995 628a
49. McLachlin J.R. Expression of a human complementary DNA for the multidrug resistance gene in murine hemopoietic precursor cells with the use of retroviral gene transfer J. Natl. Cancer Inst. 82 1990 1260 1263
50. Sorrentino B.P. Selection of drug resistant bone marrow cells in vivo after retroviral transfer of human MDR1 Science 257 1992 99 103
51. Podda S. Transfer and expression of the human multiple drug resistance gene into live mice Proc. Natl. Acad. Sci. U. S. A. 80 1992 9676 9682